p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells

Japanese Journal of Cancer Research

Volumn 91, Issue 2, 2000, Pages 164-173

  Choi, Yung Hyun ^a,c   Won Ho, Lee ^a   Park, Kun Young ^a   Zhang, Lijuan ^b  

^a Pusan National University   (South Korea)

^b NATIONAL CANCER INSTITUTE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Cell cycle; G2 M arrest; Genistein; p21

Indexed keywords

CDK2 KINASE; CYCLIN B1; DNA TOPOISOMERASE (ATP HYDROLYSING); GENISTEIN; ISOFLAVONE; PROTEIN KINASE; PROTEIN P21; PROTEIN P53; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G2 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITE; ENZYME INHIBITION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION;

EID: 0342980276     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2000.tb00928.x     Document Type: Article

References (56)

1. Amstrong, B. and Doll, R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int. J. Cancer, 15, 617-631 (1975).
2. Messina, M. and Barnes, S. The role of soy products in reducing risk of cancer. J. Natl. Cancer Inst., 83, 541-545 (1991).
3. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M. and Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinase. J. Biol. Chem., 262, 5592-5595 (1987).
4. Hunter, T. and Cooper, J. A. Protein tyrosine kinases. Annu. Rev. Biochem., 54, 897-930 (1985).
5. Ullrich, A. and Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell, 61, 203-212 (1990).
6. Cantley, L. C., Auger, K. R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R. and Soltoff, S. Oncogenes and signal transduction. Cell, 64, 281-302 (1991).
7. Markovits, J., Linassier, C., Fosse, P. H., Couprie, J., Jacquemin-Cablon. A., Saucier, J. M., Le Pecq, J. B. and Larsen, A. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase. Cancer Res., 49, 5111-5117 (1989).
8. Linassier, C., Pierre, M., Le Peco, J.-B. and Pierre, J. Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem. Pharmacol., 39, 187-193 (1990).
9. Constantinou, A., Kiguchi, K. and Huberman, E. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res., 50, 2618-2624 (1990).
10. Fotsis, T., Pepper, M., Adlercreutz, H., Fleishmann, G., Hase, T., Montesano, R. and Schweigerer, L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA, 90, 2690-2694 (1993).
11. Mueller, S. C., Yeh, Y. and Chen, W. T. Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells. J. Cell Biol., 119, 1309-1325 (1992).
12. Steele, V. E., Pereira, M. A., Sigman, C. C. and Kelloff, G. J. Cancer chemoprevention agent development strategies for genistein. J. Nutr., 125, 713S-716S (1995).
13. Cai, Q. and Wei, H. Effect of dietary genistein on antioxidant enzyme activities in Sencar mice. Nutr. Cancer, 25, 1-7 (1996).
14. Traganos, F., Ardelt, B., Halko, N., Bruno, S. and Darzynkiewicz, Z. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res., 52, 6200-6208 (1992).
15. Spinozzi, F., Pagliacci, C., Graziella, M., Rasalba, M., Grignani, F., Riccardi, C. and Nicoletti, I. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Leuk. Res., 18, 431-439 (1994).
16. Santibanez, J. F., Navapro, A. and Martinez, J. Genistein inhibits proliferation and in vitro invasive potential of human prostate cancer cell lines. Anticancer Res., 17, 1199-1204 (1997).
17. Rauth, S., Kichina, J. and Green, A. Inhibition of growth and induction of differentiation of metastatic melanoma cells in vitro by genistein: chemosensitivity is regulated by cellular p53. Br. J. Cancer, 75, 1559-1566 (1997).
18. WAF1/CIP1 induction, G2/M arrest, and apoptosis. J. Cell. Biochem., 69, 44-54 (1998).
19. Choi, Y. H., Zhang, L., Lee, W. H. and Park, K. Y. Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Int. J. Oncol., 13, 391-396 (1998).
20. Kiguchi, K., Constantinou, A. I. and Hubeman, E. Genistein-induced cell differentiation and protein-linked DNA strand breakage in human melanoma cells. Cancer Commun., 2, 271-278 (1990).
21. McCab, M. J., Jr. and Orrenius, S. Genistein induces apoptosis in mature human thymocytes by inhibiting topoisomerase II. Biochem. Biophys. Res. Commun., 194, 944-950 (1992).
22. Sherr, C. J. Mammalian G1 cyclins. Cell, 73, 1059-1065 (1993).
23. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81, 323-330 (1995).
24. Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J. and Kato, J. Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol., 14, 2066-2076 (1994).
25. Meyerson, M. and Harlow, E. Identification of G1 kinase activity for Cdk6, a novel cyclin D partner. Mol. Cell. Biol., 14, 2077-2086 (1994).
26. Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J. W., Elledge, S., Nishimoto, T., Morgan, D. O., Franza, B. R. and Roberts, J. M. Formation and activation of a cyclin E-Cdk2 complex during the G1 phase of the human cell cycle. Science, 257, 1689-1694 (1992).
27. Ohtsubo, M. and Roberts, J. M. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science, 259, 1908-1912 (1993).
28. Girard, F., Strausfeld, U., Fernandez, A. and Lamb, N. J. C. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell, 67, 1169-1179 (1991).
29. Guadagno, T. M., Ohtsubo, M., Roberts, J. M. and Assoian, R. K. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science. 262, 1572-1575 (1993).
30. Walker, D. H. and Maller, J. L. Role for cyclin A in the dependence of mitosis on comparison of DNA replication. Nature, 354, 314-317 (1991).
31. Pagano, M., Pepperkok, R., Verde, F., Ansorge, W. and Draetta, G. Cyclin A is required at two points in the human cell cycle. EMBO J., 11, 961-971 (1992).
32. Elledges, S. J. and Harper, J. W. Cdk inhibitor: on the threshold of checkpoints and development. Curr. Opin. Cell Biol., 6, 847-852 (1994).
33. Morgan, D. O. Principles of CDK regulation. Nature. 374, 131-134 (1995).
34. Gu, Y., Turck, C. W. and Morgan, D. O. Inhibition of Cdk2 activity in vivo by an associated 20 K regulatory subunit. Nature, 366, 707-710 (1993).
35. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. and Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816 (1993).
36. El-Deiry, W. S., Tokino, T., Velculesco, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, E. W., Kinzler, K. W. and Vogelstain, B. WAF1, a potential mediator of p53 suppression. Cell, 75, 817-825 (1993).
37. Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R. and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature, 366, 701-704 (1993).
38. Datto, M. B., Yu, Y. and Wang, X.-F. Functional analysis of the transforming growth factor β responsive elements in the WAF/Cip1/p21 promoter. J. Biol. Chem., 270, 28623-28628 (1995).
39. Waldman, T., Kinzler, K. W. and Vogelstain, B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res., 55, 5187-5190 (1995).
40. Jiang, H., Lin, J., Su, Z. Z., Collart, F. R., Huberman, E. and Fisher, P. B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF/CIP1, expression in the absence of p53. Oncogene, 9, 3397-3406 (1994).
41. Waga, S., Hannon, G. J., Beach, D. and Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 369, 574-578 (1994).
42. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E. and Givol, D. Induction of WAF/CIP1 by a p53-independent pathway. Cancer Res., 54, 3391-3395 (1994).
43. Zhang, W., Grasso, L., McClain, C. D., Gambel, A. M., Cha, Y., Travali, S., Deisseroth, A. B. and Mercer, W. E. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/marcrophage differentiation. Cancer Res., 55, 668-674 (1995).
44. WAF1/CIP1 expression by p53-independent pathways. Oncogene, 12, 1557-1564 (1996).
45. WAP1/CIP1 in human prostate carcinoma cells. J. Biol. Chem., 273, 10618-10623 (1998).
46. Li, Y., Jenkins, C. W., Nichols, M. A. and Xiong, Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase p21. Oncogene, 9, 2261-2268 (1994).
47. Kozlowski, J. M., Isaiah, J. F., Campbell, D., Xu, Z. L., Kaighn, M. E. and Hart, I. R. Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res., 44, 3522-3529 (1984).
48. Zi, X., Feyes, D. K. and Agarwal, R. Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinase and associated cyclins. Clin. Cancer Res., 4, 1055-1064 (1998).
49. Cdc2 kinase at the G1/S and G2/M transitions of the cell cycle: identification of major phosphorylation sites. EMBO J., 10, 305-316 (1991).
50. Ohsumi, K., Katagiri, C. and Kishimoto, T. Chromosome condensation in Xenopus mitotic extracts without histone H1. Science, 262, 2033-2035 (1993).
51. Cdc2 kinase to microtubules and is a potential regulator of M-phase microtubule dynamics. J. Cell Biol., 128, 849-862 (1995).
52. WAP1/CIP1/SDI1 protein in phorbol esterinduced G2/M arrest. J. Biol. Chem., 271, 29556-29560 (1996).
53. Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol. Cell. Biol., 18, 546-557 (1998).
54. Nakano, K., Mizuno, T., Sowa, Y., Orita, T., Yoshino, T., Okuyama, Y., Fujita, T., Ohtani-Fujita, N., Matsukawa, Y., Tokino, T., Yamagishi, H., Oka, T., Nomura, H. and Sakai, T. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J. Biol. Chem., 272, 22199-22206 (1997).
55. WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the SpI transcription factor. J. Neurosci., 17, 6122-6132 (1997).
56. WAF1 cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J. Biol. Chem., 213, 10696-10701 (1998).